VIVET THERAPEUTICS
LIVE

Serial Number

79222595

Owner

VIVET THERAPEUTICS

Attorney

JANET G RICCIUTI

Filing Date

Feb 3, 2017

Add to watchlist:

No watchlists yet
View on USPTO

VIVET THERAPEUTICS Trademark

Serial Number: 79222595 • Registration: 5592503

VIVET THERAPEUTICS is a trademark filed by VIVET THERAPEUTICS on February 3, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

VIVET THERAPEUTICS (2 trademarks)

80 boulevard Haussmann

Entity Type: 34

Trademark Details

Filing Date

February 3, 2017

Registration Date

October 30, 2018

Published for Opposition

August 14, 2018

Goods & Services

Pharmaceutical [ and veterinary ] products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, diseases of the nervous system, neuro-degenerative disorders, inflammatory and auto-immune diseases and disorders, metabolic system and endocrine system diseases and disorders [ ; immunosuppression pharmaceutical and veterinary products; sanitary preparations for medical purposes; Biological preparations for clinical medical use intended for gene therapy and cell therapy; Clinical medical reagents used for gene therapy, genetic testing and diagnosis; Cellular preparations for medical, pharmaceutical or veterinary use for gene therapy and cell therapy; Gene therapy products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, diseases of the nervous system, neuro-degenerative disorders, inflammatory and auto-immune diseases and disorders, metabolic system and endocrine system diseases and disorders; Immunosuppression gene therapy products ]

Filing History

GENERIC MADRID TRANSACTION SENT TO IB
Jul 29, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Jul 29, 2026 XXCR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 9, 2026 ADCH
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 29, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Apr 29, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Apr 29, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 28, 2025 APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 17, 2025 APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 7, 2025 APRE
TEAS SECTION 71 RECEIVED
Oct 30, 2024 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Aug 16, 2024 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 30, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2019 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 26, 2019 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 1, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 8, 2019 FICS
FINAL DISPOSITION PROCESSED
Feb 8, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 30, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 30, 2018 R.PR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 18, 2018 ADCH
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 14, 2018 NPUB
PUBLISHED FOR OPPOSITION
Aug 14, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Aug 11, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 25, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 25, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 25, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 9, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 6, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 6, 2018 TROA
REFUSAL PROCESSED BY IB
Jan 27, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 8, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jan 8, 2018 RFRR
APPLICATION FILING RECEIPT MAILED
Dec 19, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 16, 2017 RFCR
NON-FINAL ACTION WRITTEN
Dec 15, 2017 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 12, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 7, 2017 REPR